ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects.

A J Robison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.